Skip to main content

Table 2 Adjusted hazard ratios of overall survival

From: Frontline treatments in extremely elderly patients with diffuse large B-cell lymphoma: a population-based study in Taiwan, 2010–2015

VariableAged between 60 and 79 yearsAged more than 80 years
HR(95%CI)p-valueHR(95%CI)p-value
Frontline treatment
 R-CHOP1 < 0.00011 0.0003
 R-CVP1.65(1.44–1.89) 1.48(1.22–1.80) 
 CHOP1.81(1.44–2.28) 1.37(0.85–2.21) 
 CVP3.08(2.33–4.08) 1.65(1.19–2.29) 
Gender
 male1 0.00041 0.5606
 female0.82(0.73–0.91) 0.95(0.79–1.14) 
Age1.03(1.02–1.05)< 0.00011.05(1.02–1.07)0.0001
Ann Arbor stage
 I1 < 0.00011 < 0.0001
 II1.32(1.07–1.62) 1.24(0.92–1.68) 
 III2.07(1.69–2.55) 1.53(1.14–2.04) 
 IV3.06(2.52–3.70) 2.19(1.66–2.90) 
Radiotherapy
 No1 0.00671 0.5483
 Yes1.21(1.06–1.39) 1.07(0.85–1.35) 
Carlson comorbidity index
 01 < 0.00011 0.7487
 11.09(0.95–1.26) 0.94(0.75–1.18) 
 2+1.43(1.25–1.64) 1.02(0.82–1.26) 
Practice setting
 medical center1 0.01301 0.5251
 others1.16(1.03–1.30) 1.06(0.88–1.28)